Ameriprise
HRMY icon

Ameriprise’s Harmony Biosciences HRMY Stock Holding History

Ameriprise’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.47M Sell
95,316
-3,360
-3% -$106K ﹤0.01% 2796
2026
Q1 		$2.76M Sell
98,676
-122,778
-55% -$4.03M ﹤0.01% 2798
2025
Q4 		$8.29M Buy
221,454
+127,306
+135% +$4.19M ﹤0.01% 2058
2025
Q3 		$2.59M Buy
94,148
+1,542
+2% +$53.1K ﹤0.01% 2870
2025
Q2 		$2.92M Sell
92,606
-8,210
-8% -$264K ﹤0.01% 2737
2025
Q1 		$3.35M Sell
100,816
-2,985
-3% -$107K ﹤0.01% 2606
2024
Q4 		$3.57M Buy
103,801
+18,730
+22% +$644K ﹤0.01% 2599
2024
Q3 		$3.4M Sell
85,071
-2,974
-3% -$104K ﹤0.01% 2617
2024
Q2 		$2.66M Sell
88,045
-7,105
-7% -$214K ﹤0.01% 2727
2024
Q1 		$3.2M Sell
95,150
-3,916
-4% -$126K ﹤0.01% 2635
2023
Q4 		$3.2M Sell
99,066
-11,321
-10% -$316K ﹤0.01% 2624
2023
Q3 		$3.62M Buy
110,387
+1,665
+2% +$57.8K ﹤0.01% 2514
2023
Q2 		$3.83M Sell
108,722
-1,470
-1% -$50.7K ﹤0.01% 2538
2023
Q1 		$3.6M Sell
110,192
-54,190
-33% -$2.47M ﹤0.01% 2535
2022
Q4 		$9.06M Buy
164,382
+26,779
+19% +$1.47M ﹤0.01% 1818
2022
Q3 		$6.09M Buy
137,603
+42,478
+45% +$2.07M ﹤0.01% 2072
2022
Q2 		$4.64M Buy
95,125
+700
+0.7% +$31.5K ﹤0.01% 2340
2022
Q1 		$4.59M Sell
94,425
-8
-0% -$326 ﹤0.01% 2475
2021
Q4 		$4.03M Buy
+94,433
New +$3.76M ﹤0.01% 2614

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise's HRMY Position: Q2 2026 in Review

Ameriprise reduced its Harmony Biosciences (HRMY) stake by 3.4% in Q2 2026, selling an estimated $106K and leaving 95,316 shares worth $3.47M. The position accounts for ﹤0.01% of the portfolio, ranked #2796.

Ameriprise first reported a position in HRMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $9.06M in Q4 2022. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Ameriprise held 95,316 shares of Harmony Biosciences worth $3.47M as of Q2 2026.
  • Ameriprise sold 3,360 Harmony Biosciences shares in Q2 2026, an estimated $106K.
  • Harmony Biosciences made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2796 holding.
  • Ameriprise first reported a position in Harmony Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Ameriprise's Harmony Biosciences position peaked at $9.06M in Q4 2022.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.